1. Home
  2. SOBR vs ONCO Comparison

SOBR vs ONCO Comparison

Compare SOBR & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOBR Safe Inc.

SOBR

SOBR Safe Inc.

N/A

Current Price

$0.57

Market Cap

2.4M

ML Signal

N/A

Logo Onconetix Inc.

ONCO

Onconetix Inc.

N/A

Current Price

$0.83

Market Cap

2.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SOBR
ONCO
Founded
2004
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.8M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
SOBR
ONCO
Price
$0.57
$0.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.2M
192.6K
Earning Date
04-10-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
103.55
22.80
EPS
N/A
N/A
Revenue
$437,421.00
$815,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
105.62
N/A
52 Week Low
$0.35
$0.09
52 Week High
$3.95
$6.73

Technical Indicators

Market Signals
Indicator
SOBR
ONCO
Relative Strength Index (RSI) 45.09 45.96
Support Level $0.50 $0.62
Resistance Level $0.62 $0.86
Average True Range (ATR) 0.05 0.09
MACD 0.01 0.01
Stochastic Oscillator 51.91 47.82

Price Performance

Historical Comparison
SOBR
ONCO

About SOBR SOBR Safe Inc.

Sobr Safe Inc is a hardware and software company. The Company integrates proprietary software, SOBRsafeTM, with its patented touch-based personal alcohol awareness tracking products, SOBRcheckTM and SOBRsure, enabling non-invasive personal alcohol awareness tracking, biometric identity verification, and qualified, real-time cloud-based, informational alerts and reporting. It operates as a single segment designed to enable customers to purchase products directly through channel partners, sales agents or through its enterprise and consumer digital channels. Currently its principal markets are located in North America.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Share on Social Networks: